Curaleaf Holdings, Inc. CURLF shares are trading higher Thursday after the U.S. Department of Health and Human Services (HHS) recommended the rescheduling of marijuana on Wednesday.
What To Know:
According to a report from Bloomberg, Adm. Rachel Levine, the assistant secretary for health at HHS, sent a letter to the DEA Administrator, Anne Milgram, recommending that marijuana be rescheduled to a Schedule III substance.
Marijuana is currently classified as a Schedule I substance, putting it in the same category as heroin and LSD, as a drug without accepted medical treatment use and a lack of accepted safety for use under medical supervision.
Many names in the cannabis sector are soaring on the news, including Canopy Growth Corporation CGC and Tilray Brands, Inc. TLRY.
Related News: Why Tesla Stock Is Moving Higher Today
CURLF Price Action: According to Benzinga Pro, Curaleaf shares are trading 18% higher at $3.18 at the time of publication.
Image: GDJ from Pixabay
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!
